- Home
- GLOB vs ADMA Comparison
GLOB vs ADMA Comparison
Compare GLOB & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLOB
- ADMA
- Stock Information
- Founded
- GLOB 2003
- ADMA 2004
- Country
- GLOB Luxembourg
- ADMA United States
- Employees
- GLOB N/A
- ADMA N/A
- Industry
- GLOB EDP Services
- ADMA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GLOB Technology
- ADMA Health Care
- Exchange
- GLOB Nasdaq
- ADMA Nasdaq
- Market Cap
- GLOB 4.7B
- ADMA 5.1B
- IPO Year
- GLOB 2014
- ADMA N/A
- Fundamental
- Price
- GLOB $94.30
- ADMA $19.83
- Analyst Decision
- GLOB Buy
- ADMA Strong Buy
- Analyst Count
- GLOB 17
- ADMA 4
- Target Price
- GLOB $180.71
- ADMA $24.25
- AVG Volume (30 Days)
- GLOB 1.7M
- ADMA 3.4M
- Earning Date
- GLOB 05-15-2025
- ADMA 05-07-2025
- Dividend Yield
- GLOB N/A
- ADMA N/A
- EPS Growth
- GLOB N/A
- ADMA N/A
- EPS
- GLOB 3.38
- ADMA 0.84
- Revenue
- GLOB $2,455,696,000.00
- ADMA $459,381,000.00
- Revenue This Year
- GLOB $11.31
- ADMA $19.45
- Revenue Next Year
- GLOB $12.05
- ADMA $28.10
- P/E Ratio
- GLOB $29.02
- ADMA $23.74
- Revenue Growth
- GLOB 11.90
- ADMA 62.23
- 52 Week Low
- GLOB $88.03
- ADMA $9.40
- 52 Week High
- GLOB $238.32
- ADMA $25.67
- Technical
- Relative Strength Index (RSI)
- GLOB 33.12
- ADMA 46.14
- Support Level
- GLOB $99.51
- ADMA $19.28
- Resistance Level
- GLOB $107.12
- ADMA $20.14
- Average True Range (ATR)
- GLOB 4.75
- ADMA 0.74
- MACD
- GLOB -2.16
- ADMA -0.09
- Stochastic Oscillator
- GLOB 11.56
- ADMA 55.14
About GLOB Globant S.A.
Globant is a next-generation IT services company that primarily assists clients with their digital transformation efforts by creating customized software for them. The company was founded in 2003 in Argentina but is currently headquartered in Luxembourg and primarily serves clients in the US and Latin America. Globant's client base is relatively concentrated in the media and entertainment and financial services industries.
About ADMA ADMA Biologics Inc
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.